{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,3]],"date-time":"2022-04-03T23:20:01Z","timestamp":1649028001543},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2008,2,27]],"date-time":"2008-02-27T00:00:00Z","timestamp":1204070400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ophthalmologe"],"published-print":{"date-parts":[[2008,5]]},"DOI":"10.1007\/s00347-007-1632-8","type":"journal-article","created":{"date-parts":[[2008,2,25]],"date-time":"2008-02-25T11:08:50Z","timestamp":1203937730000},"page":"457-462","source":"Crossref","is-referenced-by-count":2,"title":["Bedeutung der Cyclosporin-A-Absorption f\u00fcr eine effektive immunmodulatorische Therapie nach Hochrisikokeratoplastik"],"prefix":"10.1007","volume":"105","author":[{"given":"N.","family":"Bailly","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Dunewa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Schlattmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.W.","family":"Rieck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,2,27]]},"reference":[{"key":"1632_CR1","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/eye.1993.168","volume":"7","author":"Bacon","year":"1993","unstructured":"Bacon AS, Frazer DG, Dart JK et al. (1993) A review of 72 consecutive cases of Acanthamoeba keratitis, 1984\u20131992. Eye 7: 719\u2013725","journal-title":"Eye"},{"key":"1632_CR2","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1016\/S0161-6420(95)30867-6","volume":"102","author":"Bernauer","year":"1995","unstructured":"Bernauer W, Ficker LA, Watson PG et al. (1995) The management of corneal perforations assotiated with rheumatoid arthritis. Ophthalmology 102: 1325\u20131337","journal-title":"Ophthalmology"},{"key":"1632_CR3","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1007\/s00347-003-0953-5","volume":"100","author":"Bertelmann","year":"2003","unstructured":"Bertelmann E, Reinhard T, Pleyer U (2003) Current practice of immune prophylaxis and therapy in perforating keratoplasty. A survey of members of the Cornea Section of the German Ophthalmological Society. Ophthalmologe 100: 1031\u20131035","journal-title":"Ophthalmologe"},{"key":"1632_CR4","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1111\/j.1600-0420.2006.00726.x","volume":"84","author":"Bertelmann","year":"2006","unstructured":"Bertelmann E, Pleyer U, Rieck P (2006) Risk factors for endothelial cell loss post-keratoplasty. Acta Ophthalmol Scand 84: 766\u2013770","journal-title":"Acta Ophthalmol Scand"},{"key":"1632_CR5","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1097\/01.TP.0000158022.62059.F2","volume":"79","author":"Birnbaum","year":"2005","unstructured":"Birnbaum F, Bohringer D, Sokolovska Y et al. (2005) Immunosuppression with cyclosporine A and mycophenolate mofetil after penetrating high-risk keratoplasty: a retrospective study. Transplantation 79: 964\u2013968","journal-title":"Transplantation"},{"key":"1632_CR6","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1097\/00007890-200109270-00008","volume":"72","author":"Canadian","year":"2001","unstructured":"Canadian Neoral Renal Transplantation Study Group (2001) Absorption profiling of cyclosporine microemulsion (neoral) during the first 2 weeks after renal transplantation. Transplantation 72: 1024\u20131032","journal-title":"Transplantation"},{"key":"1632_CR7","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1034\/j.1600-6143.2002.20814.x","volume":"2","author":"Clase","year":"2002","unstructured":"Clase CM, Mahalati K, Kiberd BA et al. (2002) Adequate early cyclosporin exposure is critical to prevent renal allograft rejection: patients monitored by absorption profiling. Am J Transplant 2: 789\u2013795","journal-title":"Am J Transplant"},{"key":"1632_CR8","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1097\/01.TP.0000068868.01424.61","volume":"75","author":"Cole","year":"2003","unstructured":"Cole E, Maham N, Cardella C et al. (2003) Clinical benefits of neoral C2 monitoring in the long-term management of renal transplant recipients. Transplantation 75: 2086\u20132090","journal-title":"Transplantation"},{"key":"1632_CR9","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1016\/j.ajo.2005.07.024","volume":"140","author":"Coster","year":"2005","unstructured":"Coster DJ, Williams KA (2005) The impact of corneal allograft rejection on the long-term outcome of corneal transplantation. Am J Ophthalmol 140: 1112\u20131122","journal-title":"Am J Ophthalmol"},{"key":"1632_CR10","doi-asserted-by":"crossref","first-page":"477","DOI":"10.5414\/CPP41477","volume":"41","author":"Einecke","year":"2003","unstructured":"Einecke G, Mai I, Fritsche L et al. (2003) Cyclosporin C2hour monitoring after renal transplantation. Int J Clin Pharmacol Ther 41: 477\u2013481","journal-title":"Int J Clin Pharmacol Ther"},{"key":"1632_CR11","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1097\/00007890-199904270-00008","volume":"67","author":"Grant","year":"1999","unstructured":"Grant D, Kneteman N, Tchervenkov J et al. (1999) Peak cyclosporine levels (Cmax) correlate with freedom from liver graft rejection: results of a prospective, randomized comparison of neoral and sandimmune for liver transplantation (NOF-8). Transplantation 67: 1133\u20131137","journal-title":"Transplantation"},{"key":"1632_CR12","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/S0161-6420(13)31253-6","volume":"101","author":"Hill","year":"1994","unstructured":"Hill JC (1994) Systemic cyclosporine in high-risk keratoplasty. Short- versus long-term therapy. Ophthalmology 101: 128\u2013133","journal-title":"Ophthalmology"},{"key":"1632_CR13","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1034\/j.1600-6143.2002.020206.x","volume":"2","author":"International","year":"2002","unstructured":"International Neoral Renal Transplantation Study Group (2002) Cyclosporine microemulsion (Neoral) absorption profiling and sparse-sample predictors during the first 3 months after renal transplantation. Am J Transplant 2: 148\u2013156","journal-title":"Am J Transplant"},{"key":"1632_CR14","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1097\/00007890-199609150-00010","volume":"62","author":"Kahan","year":"1996","unstructured":"Kahan BD, Welsh M, Schoenberg L et al. (1996) Variable oral absorption of cyclosporine: a biopharmaceutical risk factor for chronic renal allograft rejection. Transplantation 62: 599","journal-title":"Transplantation"},{"key":"1632_CR15","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1097\/01.ico.0000138841.44926.f8","volume":"24","author":"Koay","year":"2005","unstructured":"Koay PY, Lee WH, Figueiredo FC (2005) Opinions on risk factors and management of corneal graft rejection in the United Kingdom. Cornea 24: 292\u2013296","journal-title":"Cornea"},{"key":"1632_CR16","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/S0161-6420(00)00496-6","volume":"108","author":"Kwon","year":"2001","unstructured":"Kwon YH, Taylor JM, Hong S et al. (2001) Long-term results of eyes with penetrating keratoplasty and glaucoma drainage tube implant. Ophthalmology 108: 272\u2013278","journal-title":"Ophthalmology"},{"key":"1632_CR17","doi-asserted-by":"crossref","unstructured":"Levy G, Thervet E, Lake J, Uchida K Consensus on Neoral C(2): Expert Review in Transplantation (CONCERT) Group (2002) Patient management by Neoral C(2) monitoring: an international consensus statement. Transplantation (Suppl 9) 73: 12\u201318","DOI":"10.1097\/00007890-200205151-00003"},{"key":"1632_CR18","doi-asserted-by":"crossref","first-page":"3098","DOI":"10.1016\/S0041-1345(01)02320-X","volume":"33","author":"Maham","year":"2001","unstructured":"Maham N, Cardella C, Cattran D et al. (2001) Optimization of cyclosporine exposure utilizing C(2) level monitoring in de novo renal transplant recipients: the Toronto General Hospital experience. Transplant Proc 33: 3098\u20133099","journal-title":"Transplant Proc"},{"key":"1632_CR19","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1016\/j.healun.2004.12.112","volume":"24","author":"Mardigyan","year":"2005","unstructured":"Mardigyan V, Giannetti N, Cecere R et al. (2005) Best single time points to predict the area-under-the-curve in long-term heart transplant patients taking mycophenolate mofetil in combination with cyclosporine or tacrolimus. J Heart Lung Transplant 24: 1614\u20131618","journal-title":"J Heart Lung Transplant"},{"key":"1632_CR20","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1097\/00007691-200208000-00003","volume":"24","author":"Morris","year":"2002","unstructured":"Morris RG, Russ GR, Cervelli MJ et al. (2002) Comparison of trough, 2-hour, and limited AUC blood sampling for monitoring cyclosporin (Neoral) at day 7 post-renal transplantation and incidence of rejection in the first month. Ther Drug Monit 24: 479\u2013486","journal-title":"Ther Drug Monit"},{"key":"1632_CR21","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1034\/j.1399-0012.2002.02036.x","volume":"16","author":"Pescovitz","year":"2002","unstructured":"Pescovitz MD, Barbeito R Simulect US01 Study Group (2002) Two-hour post-dose cyclosporine level is a better predictor than trough level of acute rejection of renal allografts. Clin Transplant 16: 378\u2013382","journal-title":"Clin Transplant"},{"key":"1632_CR22","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1159\/000063847","volume":"216","author":"Pleyer","year":"2002","unstructured":"Pleyer U, Bertelmann E, Rieck P, Hartmann C (2002) Outcome of penetrating keratoplasty in rheumatoid arthritis. Ophthalmologica 216: 249\u2013255","journal-title":"Ophthalmologica"},{"key":"1632_CR23","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1055\/s-2008-1045885","volume":"201","author":"Reinhard","year":"1992","unstructured":"Reinhard T, Sundmacher R (1992) Perforierende Keratoplastik bei endogenem Ekzem. Eine Indikation f\u00fcr systemisches Ciclosporin A-eine retrospektive Studie \u00fcber 18 Patienten. Klin Monatsbl Augenheilkd 201: 159\u2013163","journal-title":"Klin Monatsbl Augenheilkd"},{"key":"1632_CR24","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1007\/s003470050146","volume":"94","author":"Reinhard","year":"1997","unstructured":"Reinhard T, Sundmacher R (1997) Systemische Cyclosporin-A Prophylaxe nach Keratoplastiken mit erh\u00f6htem Risiko f\u00fcr Immunreaktionen als einzigem erh\u00f6hten Risikofaktor. Ophthalmologe 94: 496\u2013500","journal-title":"Ophthalmologe"},{"key":"1632_CR25","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/BF02343059","volume":"Ophthalmol","author":"Reinhard","year":"1996","unstructured":"Reinhard T, Sundmacher R, Heering P (1996) Systemic ciclosporin A in high-risk keratoplasties. Graefes Arch Clin Exp Ophthalmol (Suppl 1) 234: 115\u2013121","journal-title":"Graefes Arch Clin Exp"},{"key":"1632_CR26","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1055\/s-2001-13078","volume":"218","author":"Reis","year":"2001","unstructured":"Reis A, Reinhard T, Voiculescu A et al. (2001) [Highly active antiviral and immunosuppressive combination therapy with acyclovir and mycophenolate mofetil following keratoplasty in patients with herpetic eye disease]. Klin Monatsbl Augenheilkd 218: 183\u2013186","journal-title":"Klin Monatsbl Augenheilkd"},{"key":"1632_CR27","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1136\/bjo.83.11.1268","volume":"83","author":"Reis","year":"1999","unstructured":"Reis A, Reinhard T, Voiculescu A et al. (1999) Mycophenolate mofetil versus cyclosporin A in high risk keratoplasty patients: a prospectively randomised clinical trial. Br J Ophthalmol 83: 1268\u20131271","journal-title":"Br J Ophthalmol"},{"key":"1632_CR28","first-page":"151","volume":"50","author":"Saal","year":"1991","unstructured":"Saal JG, Fritz P, Zymela B et al. (1991) Keratomalacia in rheumatoid arthritis: immunohistologic and enzyme histochemical studies. Z Rheumatol 50: 151\u2013159","journal-title":"Z Rheumatol"},{"key":"1632_CR29","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1055\/s-2005-870879","volume":"130","author":"Strunk","year":"2005","unstructured":"Strunk J, Lange U, M\u00fcller-Ladner U (2005) Rheumatoide Arthritis. Dtsch Med Wochenschr 130: 1761\u20131768","journal-title":"Dtsch Med Wochenschr"},{"key":"1632_CR30","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1016\/S0161-6420(03)00463-9","volume":"110","author":"Tompson","year":"2003","unstructured":"Tompson RW, Price MO, Bowers PJ, Price FW (2003) Long-termin grafts survival after penetrating keratoplasty. Ophthalmology 110: 1396\u20131402","journal-title":"Ophthalmology"},{"key":"1632_CR31","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1097\/01.tp.0000185197.37824.35","volume":"81","author":"Williams","year":"2006","unstructured":"Williams KA, Esterman AJ, Bartlett C et al. (2006) How effective is penetrating corneal transplantation? Factors influencing long-term outcome in multivariate analysis. Transplantation 81: 896\u2013901","journal-title":"Transplantation"}],"container-title":["Der Ophthalmologe"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00347-007-1632-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00347-007-1632-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00347-007-1632-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T13:50:49Z","timestamp":1559051449000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00347-007-1632-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,2,27]]},"references-count":31,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2008,5]]}},"alternative-id":["1632"],"URL":"https:\/\/doi.org\/10.1007\/s00347-007-1632-8","relation":{},"ISSN":["0941-293X","1433-0423"],"issn-type":[{"value":"0941-293X","type":"print"},{"value":"1433-0423","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,2,27]]}}}